-
1
-
-
0030005099
-
Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes
-
Agata Y, Kawasaki A, Nishimura H, Ishida Y, Tsubata T, Yagita H, et al. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol. 1996;8:765-72.
-
(1996)
Int Immunol.
, vol.8
, pp. 765-772
-
-
Agata, Y.1
Kawasaki, A.2
Nishimura, H.3
Ishida, Y.4
Tsubata, T.5
Yagita, H.6
-
2
-
-
70349569569
-
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
-
Ahmadzadeh M, Johnson LA, Heemskerk B, Wunderlich JR, Dudley ME, White DE, et al. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood. 2009;114:1537-44.
-
(2009)
Blood.
, vol.114
, pp. 1537-1544
-
-
Ahmadzadeh, M.1
Johnson, L.A.2
Heemskerk, B.3
Wunderlich, J.R.4
Dudley, M.E.5
White, D.E.6
-
3
-
-
0037477605
-
The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice
-
Ansari MJ, Salama AD, Chitnis T, Smith RN, Yagita H, Akiba H, et al. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med. 2003;198:63-9.
-
(2003)
J Exp Med.
, vol.198
, pp. 63-69
-
-
Ansari, M.J.1
Salama, A.D.2
Chitnis, T.3
Smith, R.N.4
Yagita, H.5
Akiba, H.6
-
4
-
-
43549115533
-
B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells
-
Azuma T, Yao S, Zhu G, Flies AS, Flies SJ, Chen L. B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells. Blood. 2008;111:3635-43.
-
(2008)
Blood.
, vol.111
, pp. 3635-3643
-
-
Azuma, T.1
Yao, S.2
Zhu, G.3
Flies, A.S.4
Flies, S.J.5
Chen, L.6
-
5
-
-
32544459770
-
Restoring function in exhausted CD8 T cells during chronic viral infection
-
Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2006;439:682-7.
-
(2006)
Nature.
, vol.439
, pp. 682-687
-
-
Barber, D.L.1
Wherry, E.J.2
Masopust, D.3
Zhu, B.4
Allison, J.P.5
Sharpe, A.H.6
-
6
-
-
49649114804
-
Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies
-
Berger R, Rotem-Yehudar R, Slama G, Landes S, Kneller A, Leiba M, et al. Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies. Clin Cancer Res. 2008;14:3044-51.
-
(2008)
Clin Cancer Res.
, vol.14
, pp. 3044-3051
-
-
Berger, R.1
Rotem-Yehudar, R.2
Slama, G.3
Landes, S.4
Kneller, A.5
Leiba, M.6
-
7
-
-
13744253833
-
Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy
-
Blank C, Gajewski TF, Mackensen A. Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy. Cancer Immunol Immunother. 2005;54:307-14.
-
(2005)
Cancer Immunol Immunother.
, vol.54
, pp. 307-314
-
-
Blank, C.1
Gajewski, T.F.2
Mackensen, A.3
-
8
-
-
0041845131
-
Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFNgamma- dependent mechanism
-
Blazar BR, Carreno BM, Panoskaltsis-Mortari A, Carter L, Iwai Y, Yagita H, et al. Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFNgamma- dependent mechanism. J Immunol. 2003;171:1272-7.
-
(2003)
J Immunol.
, vol.171
, pp. 1272-1277
-
-
Blazar, B.R.1
Carreno, B.M.2
Panoskaltsis-Mortari, A.3
Carter, L.4
Iwai, Y.5
Yagita, H.6
-
9
-
-
34247117935
-
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection
-
Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P, Giuberti T, et al. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol. 2007;81:4215-25.
-
(2007)
J Virol.
, vol.81
, pp. 4215-4225
-
-
Boni, C.1
Fisicaro, P.2
Valdatta, C.3
Amadei, B.4
Di Vincenzo, P.5
Giuberti, T.6
-
10
-
-
77954899030
-
Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates
-
Brahmer JR, Drake CG, Wollner I, Powderly JD, Picus J, Sharfman WH, et al. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol. 2010;28:3167-75.
-
(2010)
J Clin Oncol.
, vol.28
, pp. 3167-3175
-
-
Brahmer, J.R.1
Drake, C.G.2
Wollner, I.3
Powderly, J.D.4
Picus, J.5
Sharfman, W.H.6
-
11
-
-
0037307930
-
Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production
-
Brown JA, Dorfman DM, Ma FR, Sullivan EL, Munoz O, Wood CR, et al. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J Immunol. 2003;170:1257-66.
-
(2003)
J Immunol.
, vol.170
, pp. 1257-1266
-
-
Brown, J.A.1
Dorfman, D.M.2
Ma, F.R.3
Sullivan, E.L.4
Munoz, O.5
Wood, C.R.6
-
12
-
-
34447646310
-
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses
-
Butte MJ, Keir ME, Phamduy TB, Sharpe AH, Freeman GJ. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity. 2007;27:111-22.
-
(2007)
Immunity.
, vol.27
, pp. 111-122
-
-
Butte, M.J.1
Keir, M.E.2
Phamduy, T.B.3
Sharpe, A.H.4
Freeman, G.J.5
-
13
-
-
0036207926
-
PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2
-
Carter L, Fouser LA, Jussif J, Fitz L, Deng B, Wood CR, et al. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol. 2002;32:634-43.
-
(2002)
Eur J Immunol.
, vol.32
, pp. 634-643
-
-
Carter, L.1
Fouser, L.A.2
Jussif, J.3
Fitz, L.4
Deng, B.5
Wood, C.R.6
-
14
-
-
0031888608
-
Immunological ignorance of silent antigens as an explanation of tumor evasion
-
Chen L. Immunological ignorance of silent antigens as an explanation of tumor evasion. Immunol Today. 1998;19:27-30.
-
(1998)
Immunol Today.
, vol.19
, pp. 27-30
-
-
Chen, L.1
-
15
-
-
0038273853
-
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
-
Curiel TJ, Wei S, Dong H, Alvarez X, Cheng P, Mottram P, et al. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med. 2003;9:562-7.
-
(2003)
Nat Med.
, vol.9
, pp. 562-567
-
-
Curiel, T.J.1
Wei, S.2
Dong, H.3
Alvarez, X.4
Cheng, P.5
Mottram, P.6
-
16
-
-
33644558718
-
Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection
-
Das S, Suarez G, Beswick EJ, Sierra JC, Graham DY, Reyes VE. Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection. J Immunol. 2006;176:3000-9.
-
(2006)
J Immunol.
, vol.176
, pp. 3000-3009
-
-
Das, S.1
Suarez, G.2
Beswick, E.J.3
Sierra, J.C.4
Graham, D.Y.5
Reyes, V.E.6
-
17
-
-
33748947326
-
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
-
Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006;443:350-4.
-
(2006)
Nature.
, vol.443
, pp. 350-354
-
-
Day, C.L.1
Kaufmann, D.E.2
Kiepiela, P.3
Brown, J.A.4
Moodley, E.S.5
Reddy, S.6
-
18
-
-
0038796692
-
B7-H1 pathway and its role in the evasion of tumor immunity
-
Dong H, Chen L. B7-H1 pathway and its role in the evasion of tumor immunity. J Mol Med. 2003;81:281-7.
-
(2003)
J Mol Med.
, vol.81
, pp. 281-287
-
-
Dong, H.1
Chen, L.2
-
19
-
-
18544380239
-
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion
-
Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med. 2002;8:793-800.
-
(2002)
Nat Med.
, vol.8
, pp. 793-800
-
-
Dong, H.1
Strome, S.E.2
Salomao, D.R.3
Tamura, H.4
Hirano, F.5
Flies, D.B.6
-
20
-
-
1642306942
-
B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes
-
Dong H, Zhu G, Tamada K, Flies DB, van Deursen JM, Chen L. B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. Immunity. 2004;20:327-36.
-
(2004)
Immunity.
, vol.20
, pp. 327-336
-
-
Dong, H.1
Zhu, G.2
Tamada, K.3
Flies, D.B.4
van Deursen, J.M.5
Chen, L.6
-
21
-
-
73949088551
-
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
-
Francisco LM, Salinas VH, Brown KE, Vanguri VK, Freeman GJ, Kuchroo VK, et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med. 2009;206:3015-29.
-
(2009)
J Exp Med.
, vol.206
, pp. 3015-3029
-
-
Francisco, L.M.1
Salinas, V.H.2
Brown, K.E.3
Vanguri, V.K.4
Freeman, G.J.5
Kuchroo, V.K.6
-
22
-
-
49649093382
-
B7-H1 up-regulated expression in human pancreatic carcinoma tissue associates with tumor progression
-
Geng L, Huang D, Liu J, Qian Y, Deng J, Li D, et al. B7-H1 up-regulated expression in human pancreatic carcinoma tissue associates with tumor progression. J Cancer Res Clin Oncol. 2008;134:1021-7.
-
(2008)
J Cancer Res Clin Oncol.
, vol.134
, pp. 1021-1027
-
-
Geng, L.1
Huang, D.2
Liu, J.3
Qian, Y.4
Deng, J.5
Li, D.6
-
23
-
-
33646367200
-
The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors
-
Ghebeh H, Mohammed S, Al-Omair A, Qattan A, Lehe C, Al-Qudaihi G, et al. The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. Neoplasia. 2006;8:190-8.
-
(2006)
Neoplasia.
, vol.8
, pp. 190-198
-
-
Ghebeh, H.1
Mohammed, S.2
Al-Omair, A.3
Qattan, A.4
Lehe, C.5
Al-Qudaihi, G.6
-
24
-
-
34347389213
-
Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells
-
Goldberg MV, Maris CH, Hipkiss EL, Flies AS, Zhen L, Tuder RM, et al. Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells. Blood. 2007;110:186-92.
-
(2007)
Blood.
, vol.110
, pp. 186-192
-
-
Goldberg, M.V.1
Maris, C.H.2
Hipkiss, E.L.3
Flies, A.S.4
Zhen, L.5
Tuder, R.M.6
-
25
-
-
22944436502
-
A critical role for the programmed death ligand 1 in fetomaternal tolerance
-
Guleria I, Khosroshahi A, Ansari MJ, Habicht A, Azuma M, Yagita H, et al. A critical role for the programmed death ligand 1 in fetomaternal tolerance. J Exp Med. 2005;202:231-7.
-
(2005)
J Exp Med.
, vol.202
, pp. 231-237
-
-
Guleria, I.1
Khosroshahi, A.2
Ansari, M.J.3
Habicht, A.4
Azuma, M.5
Yagita, H.6
-
26
-
-
33847611968
-
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer
-
Hamanishi J, Mandai M, Iwasaki M, Okazaki T, Tanaka Y, Yamaguchi K, et al. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer. Proc Natl Acad Sci USA. 2007;104:3360-5.
-
(2007)
Proc Natl Acad Sci USA.
, vol.104
, pp. 3360-3365
-
-
Hamanishi, J.1
Mandai, M.2
Iwasaki, M.3
Okazaki, T.4
Tanaka, Y.5
Yamaguchi, K.6
-
27
-
-
77950283280
-
Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma
-
Hino R, Kabashima K, Kato Y, Yagi H, Nakamura M, Honjo T, et al. Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma. Cancer. 2010;116:1757-66.
-
(2010)
Cancer.
, vol.116
, pp. 1757-1766
-
-
Hino, R.1
Kabashima, K.2
Kato, Y.3
Yagi, H.4
Nakamura, M.5
Honjo, T.6
-
28
-
-
13444270323
-
Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity
-
Hirano F, Kaneko K, Tamura H, Dong H, Wang S, Ichikawa M, et al. Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. Cancer Res. 2005;65:1089-96.
-
(2005)
Cancer Res.
, vol.65
, pp. 1089-1096
-
-
Hirano, F.1
Kaneko, K.2
Tamura, H.3
Dong, H.4
Wang, S.5
Ichikawa, M.6
-
29
-
-
21344456553
-
Role of B7-H1 and B7-H4 molecules in down-regulating effector phase of T-cell immunity: novel cancer escaping mechanisms
-
Ichikawa M, Chen L. Role of B7-H1 and B7-H4 molecules in down-regulating effector phase of T-cell immunity: novel cancer escaping mechanisms. Front Biosci. 2005;10:2856-60.
-
(2005)
Front Biosci.
, vol.10
, pp. 2856-2860
-
-
Ichikawa, M.1
Chen, L.2
-
30
-
-
34247113727
-
PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression
-
Inman BA, Sebo TJ, Frigola X, Dong H, Bergstralh EJ, Frank I, et al. PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression. Cancer. 2007;109:1499-505.
-
(2007)
Cancer.
, vol.109
, pp. 1499-1505
-
-
Inman, B.A.1
Sebo, T.J.2
Frigola, X.3
Dong, H.4
Bergstralh, E.J.5
Frank, I.6
-
31
-
-
0037126021
-
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
-
Iwai Y, Ishida M, Tanaka Y, Okazaki T, Honjo T, Minato N. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc Natl Acad Sci USA. 2002;99:12293-7.
-
(2002)
Proc Natl Acad Sci USA.
, vol.99
, pp. 12293-12297
-
-
Iwai, Y.1
Ishida, M.2
Tanaka, Y.3
Okazaki, T.4
Honjo, T.5
Minato, N.6
-
32
-
-
13844294372
-
PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells
-
Iwai Y, Terawaki S, Honjo T. PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells. Int Immunol. 2005;17:133-44.
-
(2005)
Int Immunol.
, vol.17
, pp. 133-144
-
-
Iwai, Y.1
Terawaki, S.2
Honjo, T.3
-
33
-
-
47949107182
-
Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis
-
Jurado JO, Alvarez IB, Pasquinelli V, Martinez GJ, Quiroga MF, Abbate E, et al. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J Immunol. 2008;181:116-25.
-
(2008)
J Immunol.
, vol.181
, pp. 116-125
-
-
Jurado, J.O.1
Alvarez, I.B.2
Pasquinelli, V.3
Martinez, G.J.4
Quiroga, M.F.5
Abbate, E.6
-
34
-
-
70350247885
-
Tumor-expressed B7-H1 and B7-DC in relation to PD-1+ T-cell infiltration and survival of patients with cervical carcinoma
-
Karim R, Jordanova ES, Piersma SJ, Kenter GG, Chen L, Boer JM, et al. Tumor-expressed B7-H1 and B7-DC in relation to PD-1+ T-cell infiltration and survival of patients with cervical carcinoma. Clin Cancer Res. 2009;15:6341-7.
-
(2009)
Clin Cancer Res.
, vol.15
, pp. 6341-6347
-
-
Karim, R.1
Jordanova, E.S.2
Piersma, S.J.3
Kenter, G.G.4
Chen, L.5
Boer, J.M.6
-
35
-
-
70350743827
-
PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention
-
Kaufmann DE, Walker BD. PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention. J Immunol. 2009;182:5891-7.
-
(2009)
J Immunol.
, vol.182
, pp. 5891-5897
-
-
Kaufmann, D.E.1
Walker, B.D.2
-
37
-
-
58149191881
-
The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands
-
Kinter AL, Godbout EJ, McNally JP, Sereti I, Roby GA, O'Shea MA, et al. The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. J Immunol. 2008;181:6738-46.
-
(2008)
J Immunol.
, vol.181
, pp. 6738-6746
-
-
Kinter, A.L.1
Godbout, E.J.2
McNally, J.P.3
Sereti, I.4
Roby, G.A.5
O'Shea, M.A.6
-
38
-
-
4243096258
-
B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression
-
Konishi J, Yamazaki K, Azuma M, Kinoshita I, Dosaka-Akita H, Nishimura M. B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression. Clin Cancer Res. 2004;10:5094-100.
-
(2004)
Clin Cancer Res.
, vol.10
, pp. 5094-5100
-
-
Konishi, J.1
Yamazaki, K.2
Azuma, M.3
Kinoshita, I.4
Dosaka-Akita, H.5
Nishimura, M.6
-
39
-
-
63449124514
-
Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor-secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors
-
Li B, VanRoey M, Wang C, Chen TH, Korman A, Jooss K. Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor-secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors. Clin Cancer Res. 2009;15:1623-34.
-
(2009)
Clin Cancer Res.
, vol.15
, pp. 1623-1634
-
-
Li, B.1
VanRoey, M.2
Wang, C.3
Chen, T.H.4
Korman, A.5
Jooss, K.6
-
40
-
-
0242303572
-
Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses
-
Liang SC, Latchman YE, Buhlmann JE, Tomczak MF, Horwitz BH, Freeman GJ, et al. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur J Immunol. 2003;33:2706-16.
-
(2003)
Eur J Immunol.
, vol.33
, pp. 2706-2716
-
-
Liang, S.C.1
Latchman, Y.E.2
Buhlmann, J.E.3
Tomczak, M.F.4
Horwitz, B.H.5
Freeman, G.J.6
-
41
-
-
10744226932
-
B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanism
-
Matsumoto K, Inoue H, Nakano T, Tsuda M, Yoshiura Y, Fukuyama S, et al. B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanism. J Immunol. 2004;172:2530-41.
-
(2004)
J Immunol.
, vol.172
, pp. 2530-2541
-
-
Matsumoto, K.1
Inoue, H.2
Nakano, T.3
Tsuda, M.4
Yoshiura, Y.5
Fukuyama, S.6
-
42
-
-
34248586083
-
Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers
-
Nakanishi J, Wada Y, Matsumoto K, Azuma M, Kikuchi K, Ueda S. Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers. Cancer Immunol Immunother. 2007;56:1173-82.
-
(2007)
Cancer Immunol Immunother.
, vol.56
, pp. 1173-1182
-
-
Nakanishi, J.1
Wada, Y.2
Matsumoto, K.3
Azuma, M.4
Kikuchi, K.5
Ueda, S.6
-
43
-
-
0034927194
-
PD-1: an inhibitory immunoreceptor involved in peripheral tolerance
-
Nishimura H, Honjo T. PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol. 2001;22:265-8.
-
(2001)
Trends Immunol.
, vol.22
, pp. 265-268
-
-
Nishimura, H.1
Honjo, T.2
-
44
-
-
0033180181
-
Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor
-
Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity. 1999;11:141-51.
-
(1999)
Immunity.
, vol.11
, pp. 141-151
-
-
Nishimura, H.1
Nose, M.2
Hiai, H.3
Minato, N.4
Honjo, T.5
-
45
-
-
0035846991
-
Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice
-
Nishimura H, Okazaki T, Tanaka Y, Nakatani K, Hara M, Matsumori A, et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science. 2001;291:319-22.
-
(2001)
Science.
, vol.291
, pp. 319-322
-
-
Nishimura, H.1
Okazaki, T.2
Tanaka, Y.3
Nakatani, K.4
Hara, M.5
Matsumori, A.6
-
46
-
-
34247532726
-
Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer
-
Nomi T, Sho M, Akahori T, Hamada K, Kubo A, Kanehiro H, et al. Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer. Clin Cancer Res. 2007;13:2151-7.
-
(2007)
Clin Cancer Res.
, vol.13
, pp. 2151-2157
-
-
Nomi, T.1
Sho, M.2
Akahori, T.3
Hamada, K.4
Kubo, A.5
Kanehiro, H.6
-
47
-
-
20244384862
-
Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer
-
Ohigashi Y, Sho M, Yamada Y, Tsurui Y, Hamada K, Ikeda N, et al. Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer. Clin Cancer Res. 2005;11:2947-53.
-
(2005)
Clin Cancer Res.
, vol.11
, pp. 2947-2953
-
-
Ohigashi, Y.1
Sho, M.2
Yamada, Y.3
Tsurui, Y.4
Hamada, K.5
Ikeda, N.6
-
48
-
-
10744220884
-
Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice
-
Okazaki T, Tanaka Y, Nishio R, Mitsuiye T, Mizoguchi A, Wang J, et al. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med. 2003;9:1477-83.
-
(2003)
Nat Med.
, vol.9
, pp. 1477-1483
-
-
Okazaki, T.1
Tanaka, Y.2
Nishio, R.3
Mitsuiye, T.4
Mizoguchi, A.5
Wang, J.6
-
49
-
-
77956496386
-
B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T cell tolerance
-
Park JJ, Omiya R, Matsumura Y, Sakoda Y, Kuramasu A, Augustine MM, et al. B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T cell tolerance. Blood. 2010;116(8):1291-8.
-
(2010)
Blood.
, vol.116
, Issue.8
, pp. 1291-1298
-
-
Park, J.J.1
Omiya, R.2
Matsumura, Y.3
Sakoda, Y.4
Kuramasu, A.5
Augustine, M.M.6
-
50
-
-
27144496045
-
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
-
Parry RV, Chemnitz JM, Frauwirth KA, Lanfranco AR, Braunstein I, Kobayashi SV, et al. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol. 2005;25:9543-53.
-
(2005)
Mol Cell Biol.
, vol.25
, pp. 9543-9553
-
-
Parry, R.V.1
Chemnitz, J.M.2
Frauwirth, K.A.3
Lanfranco, A.R.4
Braunstein, I.5
Kobayashi, S.V.6
-
51
-
-
33846118474
-
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
-
Parsa AT, Waldron JS, Panner A, Crane CA, Parney IF, Barry JJ, et al. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nat Med. 2007;13:84-8.
-
(2007)
Nat Med.
, vol.13
, pp. 84-88
-
-
Parsa, A.T.1
Waldron, J.S.2
Panner, A.3
Crane, C.A.4
Parney, I.F.5
Barry, J.J.6
-
52
-
-
33947421722
-
Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection
-
Penna A, Pilli M, Zerbini A, Orlandini A, Mezzadri S, Sacchelli L, et al. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology. 2007;45:588-601.
-
(2007)
Hepatology.
, vol.45
, pp. 588-601
-
-
Penna, A.1
Pilli, M.2
Zerbini, A.3
Orlandini, A.4
Mezzadri, S.5
Sacchelli, L.6
-
53
-
-
41749091806
-
B7-H1 expression in Wilms tumor: correlation with tumor biology and disease recurrence
-
discussion 1959-60
-
Routh JC, Ashley RA, Sebo TJ, Lohse CM, Husmann DA, Kramer SA, et al. B7-H1 expression in Wilms tumor: correlation with tumor biology and disease recurrence. J Urol. 2008;179:1954-9; discussion 1959-60.
-
(2008)
J Urol.
, vol.179
, pp. 1954-1959
-
-
Routh, J.C.1
Ashley, R.A.2
Sebo, T.J.3
Lohse, C.M.4
Husmann, D.A.5
Kramer, S.A.6
-
54
-
-
0037477604
-
Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis
-
Salama AD, Chitnis T, Imitola J, Ansari MJ, Akiba H, Tushima F, et al. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J Exp Med. 2003;198:71-8.
-
(2003)
J Exp Med.
, vol.198
, pp. 71-78
-
-
Salama, A.D.1
Chitnis, T.2
Imitola, J.3
Ansari, M.J.4
Akiba, H.5
Tushima, F.6
-
55
-
-
20144376357
-
Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo
-
Sandner SE, Clarkson MR, Salama AD, Sanchez-Fueyo A, Domenig C, Habicht A, et al. Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo. J Immunol. 2005;174:3408-15.
-
(2005)
J Immunol.
, vol.174
, pp. 3408-3415
-
-
Sandner, S.E.1
Clarkson, M.R.2
Salama, A.D.3
Sanchez-Fueyo, A.4
Domenig, C.5
Habicht, A.6
-
56
-
-
29744462591
-
PD-L2:PD-1 involvement in T cell proliferation, cytokine production, and integrin-mediated adhesion
-
Saunders PA, Hendrycks VR, Lidinsky WA, Woods ML. PD-L2:PD-1 involvement in T cell proliferation, cytokine production, and integrin-mediated adhesion. Eur J Immunol. 2005;35:3561-9.
-
(2005)
Eur J Immunol.
, vol.35
, pp. 3561-3569
-
-
Saunders, P.A.1
Hendrycks, V.R.2
Lidinsky, W.A.3
Woods, M.L.4
-
57
-
-
34848915783
-
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase
-
Sharma MD, Baban B, Chandler P, Hou DY, Singh N, Yagita H, et al. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J Clin Invest. 2007;117:2570-82.
-
(2007)
J Clin Invest.
, vol.117
, pp. 2570-2582
-
-
Sharma, M.D.1
Baban, B.2
Chandler, P.3
Hou, D.Y.4
Singh, N.5
Yagita, H.6
-
58
-
-
4444317516
-
PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta
-
Sheppard KA, Fitz LJ, Lee JM, Benander C, George JA, Wooters J, et al. PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta. FEBS Lett. 2004;574:37-41.
-
(2004)
FEBS Lett.
, vol.574
, pp. 37-41
-
-
Sheppard, K.A.1
Fitz, L.J.2
Lee, J.M.3
Benander, C.4
George, J.A.5
Wooters, J.6
-
59
-
-
33749430399
-
Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner
-
Skeen JE, Bhaskar PT, Chen CC, Chen WS, Peng XD, Nogueira V, et al. Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner. Cancer Cell. 2006;10:269-80.
-
(2006)
Cancer Cell.
, vol.10
, pp. 269-280
-
-
Skeen, J.E.1
Bhaskar, P.T.2
Chen, C.C.3
Chen, W.S.4
Peng, X.D.5
Nogueira, V.6
-
60
-
-
0141953992
-
B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma
-
Strome SE, Dong H, Tamura H, Voss SG, Flies DB, Tamada K, et al. B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. Cancer Res. 2003;63:6501-5.
-
(2003)
Cancer Res.
, vol.63
, pp. 6501-6505
-
-
Strome, S.E.1
Dong, H.2
Tamura, H.3
Voss, S.G.4
Flies, D.B.5
Tamada, K.6
-
61
-
-
77955917121
-
Safety and antitumor activity of biweekly MDX-1106 (anti-PD-1, BMS-936558/ONO-4538) in patients with advanced refractory malignancies (Meeting Abstracts)
-
abstr 2506
-
Sznol, M., Powderly, J.D., Smith, D.C., Brahmer, J.R., Drake, C.G., McDermott, D.F., Lawrence, D.P., Wolchok, J.D., Topalian, S.L., and Lowy, I. (2010). Safety and antitumor activity of biweekly MDX-1106 (anti-PD-1, BMS-936558/ONO-4538) in patients with advanced refractory malignancies (Meeting Abstracts). J Clin Oncol 28 (suppl; abstr 2506).
-
(2010)
J Clin Oncol
, vol.28
-
-
Sznol, M.1
Powderly, J.D.2
Smith, D.C.3
Brahmer, J.R.4
Drake, C.G.5
McDermott, D.F.6
Lawrence, D.P.7
Wolchok, J.D.8
Topalian, S.L.9
Lowy, I.10
-
62
-
-
34250177269
-
PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma
-
Thompson RH, Dong H, Lohse CM, Leibovich BC, Blute ML, Cheville JC, et al. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma. Clin Cancer Res. 2007;13:1757-61.
-
(2007)
Clin Cancer Res.
, vol.13
, pp. 1757-1761
-
-
Thompson, R.H.1
Dong, H.2
Lohse, C.M.3
Leibovich, B.C.4
Blute, M.L.5
Cheville, J.C.6
-
63
-
-
27644562256
-
Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma
-
Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, et al. Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma. Cancer. 2005;104:2084-91.
-
(2005)
Cancer.
, vol.104
, pp. 2084-2091
-
-
Thompson, R.H.1
Gillett, M.D.2
Cheville, J.C.3
Lohse, C.M.4
Dong, H.5
Webster, W.S.6
-
64
-
-
10344220548
-
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
-
Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, et al. Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target. Proc Natl Acad Sci USA. 2004;101:17174-9.
-
(2004)
Proc Natl Acad Sci USA.
, vol.101
, pp. 17174-17179
-
-
Thompson, R.H.1
Gillett, M.D.2
Cheville, J.C.3
Lohse, C.M.4
Dong, H.5
Webster, W.S.6
-
65
-
-
33645736792
-
Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow- up
-
Thompson RH, Kuntz SM, Leibovich BC, Dong H, Lohse CM, Webster WS, et al. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow- up. Cancer Res. 2006;66:3381-5.
-
(2006)
Cancer Res.
, vol.66
, pp. 3381-3385
-
-
Thompson, R.H.1
Kuntz, S.M.2
Leibovich, B.C.3
Dong, H.4
Lohse, C.M.5
Webster, W.S.6
-
66
-
-
0028867420
-
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
-
Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 1995;3:541-7.
-
(1995)
Immunity.
, vol.3
, pp. 541-547
-
-
Tivol, E.A.1
Borriello, F.2
Schweitzer, A.N.3
Lynch, W.P.4
Bluestone, J.A.5
Sharpe, A.H.6
-
67
-
-
0024390061
-
Tumor-specific cytolysis by lymphocytes infiltrating human melanomas
-
Topalian SL, Solomon D, Rosenberg SA. Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J Immunol. 1989;142:3714-25.
-
(1989)
J Immunol.
, vol.142
, pp. 3714-3725
-
-
Topalian, S.L.1
Solomon, D.2
Rosenberg, S.A.3
-
68
-
-
33749009709
-
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
-
Trautmann L, Janbazian L, Chomont N, Said EA, Gimmig S, Bessette B, et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med. 2006;12:1198-202.
-
(2006)
Nat Med.
, vol.12
, pp. 1198-1202
-
-
Trautmann, L.1
Janbazian, L.2
Chomont, N.3
Said, E.A.4
Gimmig, S.5
Bessette, B.6
-
69
-
-
34347371572
-
Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy
-
Tsushima F, Yao S, Shin T, Flies A, Flies S, Xu H, et al. Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy. Blood. 2007;110:180-5.
-
(2007)
Blood.
, vol.110
, pp. 180-185
-
-
Tsushima, F.1
Yao, S.2
Shin, T.3
Flies, A.4
Flies, S.5
Xu, H.6
-
70
-
-
33750691709
-
PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion
-
Urbani S, Amadei B, Tola D, Massari M, Schivazappa S, Missale G, et al. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J Virol. 2006;80:11398-403.
-
(2006)
J Virol.
, vol.80
, pp. 11398-11403
-
-
Urbani, S.1
Amadei, B.2
Tola, D.3
Massari, M.4
Schivazappa, S.5
Missale, G.6
-
71
-
-
23844529169
-
Establishment of NOD-Pdcd1 -/- mice as an efficient animal model of type I diabetes
-
Wang J, Yoshida T, Nakaki F, Hiai H, Okazaki T, Honjo T. Establishment of NOD-Pdcd1 -/- mice as an efficient animal model of type I diabetes. Proc Natl Acad Sci USA. 2005;102:11823-8.
-
(2005)
Proc Natl Acad Sci USA.
, vol.102
, pp. 11823-11828
-
-
Wang, J.1
Yoshida, T.2
Nakaki, F.3
Hiai, H.4
Okazaki, T.5
Honjo, T.6
-
72
-
-
77954716038
-
Clinical significance of b7-h1 and b7-1 expressions in pancreatic carcinoma
-
Wang L, Ma Q, Chen X, Guo K, Li J, Zhang M. Clinical significance of b7-h1 and b7-1 expressions in pancreatic carcinoma. World J Surg. 2010;34:1059-65.
-
(2010)
World J Surg.
, vol.34
, pp. 1059-1065
-
-
Wang, L.1
Ma, Q.2
Chen, X.3
Guo, K.4
Li, J.5
Zhang, M.6
-
73
-
-
69749106159
-
PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells
-
Wang W, Lau R, Yu D, Zhu W, Korman A, Weber J. PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells. Int Immunol. 2009;21:1065-77.
-
(2009)
Int Immunol.
, vol.21
, pp. 1065-1077
-
-
Wang, W.1
Lau, R.2
Yu, D.3
Zhu, W.4
Korman, A.5
Weber, J.6
-
74
-
-
0028791059
-
Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4
-
Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 1995;270:985-8.
-
(1995)
Science.
, vol.270
, pp. 985-988
-
-
Waterhouse, P.1
Penninger, J.M.2
Timms, E.3
Wakeham, A.4
Shahinian, A.5
Lee, K.P.6
-
75
-
-
38449107219
-
Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine
-
Webster WS, Thompson RH, Harris KJ, Frigola X, Kuntz S, Inman BA, et al. Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine. J Immunol. 2007;179:2860-9.
-
(2007)
J Immunol.
, vol.179
, pp. 2860-2869
-
-
Webster, W.S.1
Thompson, R.H.2
Harris, K.J.3
Frigola, X.4
Kuntz, S.5
Inman, B.A.6
-
76
-
-
0242442492
-
Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis
-
Wintterle S, Schreiner B, Mitsdoerffer M, Schneider D, Chen L, Meyermann R, et al. Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis. Cancer Res. 2003;63:7462-7.
-
(2003)
Cancer Res.
, vol.63
, pp. 7462-7467
-
-
Wintterle, S.1
Schreiner, B.2
Mitsdoerffer, M.3
Schneider, D.4
Chen, L.5
Meyermann, R.6
-
77
-
-
34848900497
-
Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs
-
Wong RM, Scotland RR, Lau RL, Wang C, Korman AJ, Kast WM, et al. Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs. Int Immunol. 2007;19:1223-34.
-
(2007)
Int Immunol.
, vol.19
, pp. 1223-1234
-
-
Wong, R.M.1
Scotland, R.R.2
Lau, R.L.3
Wang, C.4
Korman, A.J.5
Kast, W.M.6
-
78
-
-
33745491116
-
Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance
-
Wu C, Zhu Y, Jiang J, Zhao J, Zhang XG, Xu N. Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance. Acta Histochem. 2006;108:19-24.
-
(2006)
Acta Histochem.
, vol.108
, pp. 19-24
-
-
Wu, C.1
Zhu, Y.2
Jiang, J.3
Zhao, J.4
Zhang, X.G.5
Xu, N.6
-
79
-
-
0037111483
-
Expression of programmed death 1 ligands by murine T cells and APC
-
Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y, et al. Expression of programmed death 1 ligands by murine T cells and APC. J Immunol. 2002;169:5538-45.
-
(2002)
J Immunol.
, vol.169
, pp. 5538-5545
-
-
Yamazaki, T.1
Akiba, H.2
Iwai, H.3
Matsuda, H.4
Aoki, M.5
Tanno, Y.6
|